BMNDF
Price
$0.10
Change
-$0.00 (-0.00%)
Updated
Jun 25 closing price
Capitalization
19.79M
VIGL
Price
$7.95
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
370.81M
44 days until earnings call
Interact to see
Advertisement

BMNDF vs VIGL

Header iconBMNDF vs VIGL Comparison
Open Charts BMNDF vs VIGLBanner chart's image
BIOMIND LABS
Price$0.10
Change-$0.00 (-0.00%)
Volume$4.02K
Capitalization19.79M
Vigil Neuroscience
Price$7.95
Change-$0.00 (-0.00%)
Volume$303.98K
Capitalization370.81M
BMNDF vs VIGL Comparison Chart in %
Loading...
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMNDF vs. VIGL commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMNDF is a Hold and VIGL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BMNDF: $0.10 vs. VIGL: $7.95)
Brand notoriety: BMNDF and VIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMNDF: 326% vs. VIGL: 22%
Market capitalization -- BMNDF: $19.79M vs. VIGL: $370.81M
BMNDF [@Biotechnology] is valued at $19.79M. VIGL’s [@Biotechnology] market capitalization is $370.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMNDF’s FA Score shows that 0 FA rating(s) are green whileVIGL’s FA Score has 0 green FA rating(s).

  • BMNDF’s FA Score: 0 green, 5 red.
  • VIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, VIGL is a better buy in the long-term than BMNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMNDF’s TA Score shows that 1 TA indicator(s) are bullish while VIGL’s TA Score has 3 bullish TA indicator(s).

  • BMNDF’s TA Score: 1 bullish, 3 bearish.
  • VIGL’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both BMNDF and VIGL are a bad buy in the short-term.

Price Growth

BMNDF (@Biotechnology) experienced а 0.00% price change this week, while VIGL (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VIGL is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VIGL($371M) has a higher market cap than BMNDF($19.8M). VIGL YTD gains are higher at: 367.647 vs. BMNDF (-67.490). BMNDF has higher annual earnings (EBITDA): -314.15K vs. VIGL (-91.27M). VIGL has more cash in the bank: 87.1M vs. BMNDF (10.1K). BMNDF has less debt than VIGL: BMNDF (883K) vs VIGL (12.7M). BMNDF (0) and VIGL (0) have equivalent revenues.
BMNDFVIGLBMNDF / VIGL
Capitalization19.8M371M5%
EBITDA-314.15K-91.27M0%
Gain YTD-67.490367.647-18%
P/E RatioN/AN/A-
Revenue00-
Total Cash10.1K87.1M0%
Total Debt883K12.7M7%
FUNDAMENTALS RATINGS
BMNDF: Fundamental Ratings
BMNDF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BMNDFVIGL
RSI
ODDS (%)
Bullish Trend 3 days ago
53%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
N/A
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bearish Trend 3 days ago
31%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
43%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
42%
Bullish Trend 3 days ago
88%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
POSAF0.05N/A
+0.57%
Posabit Systems Corporation
FPAFF0.75N/A
N/A
First Pacific Company Ltd.
SHMUY43.65N/A
N/A
Shimizu Corp.
TAGP0.05N/A
N/A
Tristar Acquisition Group
STOHF24.89-0.67
-2.63%
Equinor ASA

BMNDF and

Correlation & Price change

A.I.dvisor tells us that BMNDF and CLVLY have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and CLVLY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
CLVLY - BMNDF
26%
Poorly correlated
-2.58%
RGLS - BMNDF
24%
Poorly correlated
N/A
MLLCF - BMNDF
21%
Poorly correlated
N/A
VIGL - BMNDF
20%
Poorly correlated
N/A
CYDY - BMNDF
12%
Poorly correlated
-14.17%
More

VIGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIGL has been loosely correlated with MRUS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VIGL jumps, then MRUS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIGL
1D Price
Change %
VIGL100%
N/A
MRUS - VIGL
49%
Loosely correlated
-0.47%
IMNN - VIGL
46%
Loosely correlated
-7.34%
ELVN - VIGL
35%
Loosely correlated
-3.95%
VYGR - VIGL
32%
Poorly correlated
-0.34%
VTGN - VIGL
31%
Poorly correlated
-3.90%
More